Top Suppliers:I want be here
Related CAS#:
57-91-0 81586-94-9
24703-07-9 4145-55-5
74561-57-2 1228-72-4
6045-52-9 67069-13-0
60305-23-9 13900-61-3
1158522-08-7 1403574-26-4
940364-43-2 134104-43-1
131615-57-1 2490402-46-3
2171696-49-2 6906-52-1
2640898-99-1 930439-75-1

57-91-0

57-91-0 structure
57-91-0 structure
  • Name: 17alpha-Estradiol
  • Chemical Name: 17α-estradiol
  • CAS Number: 57-91-0
  • Molecular Formula: C18H24O2
  • Molecular Weight: 272.382
  • Catalog: API Antibiotics Other antibiotics
  • Create Date: 2018-09-16 12:31:25
  • Modify Date: 2024-01-02 14:34:40
  • Alpha-Estradiol is a weak estrogen and a 5α-reductase inhibitor which is used as a topical medication in the treatment of androgenic alopecia.
Name 17α-estradiol
Synonyms α-Estradiol
a-Estradiol
Oestra-1,3,5(10)-triene-3,17α-diol
alfatradiol
MFCD00064144
(17a)-Estra-1,3,5(10)-triene-3,17-diol
3,17α-Dihydroxyestra-1,3,5(10)-triene
Estra-1,3,5(10)-triene-3,17-diol, (17α)-
trans-4-Hydroxycrotonic acid
Epiestradiol
Epiestrol
Estra-1,3,5(10)-triene-3,17a-diol
3,17-α-Dihydroxyoestra-1,3,5(10)-triene
(17α)-Estra-1,3,5(10)-triene-3,17-diol
3,17a-Dihydroxyestra-1,3,5(10)-triene
Oestradiol-17a
3,17a-Dihydroxyoestra-1,3,5(10)-triene
Oestra-1,3,5(10)-triene-3,17a-diol
17-Epiestradiol
17α-Oestradiol
3,17α-Dihydroxyoestra-1,3,5(10)-triene
17a-Estradiol
17α-Estradiol
17α estradiol
Oestradiol-17α
(8R,9S,13S,14S,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
Epiestradial
Estradiol, 17α-
EINECS 200-023-8
13b-Methyl-1,3,5(10)-gonatriene-3,17a-diol
17a-Oestradiol
17alpha-Estradiol
3,17-Dihydroxyestratriene
Estradiol-17alpha
Description Alpha-Estradiol is a weak estrogen and a 5α-reductase inhibitor which is used as a topical medication in the treatment of androgenic alopecia.
Related Catalog
Target

Human Endogenous Metabolite

In Vitro Alpha-Estradiol (17 alpha-Estradiol) is a 5α-reductase inhibitor, and inhibits testosterone metabolism catalyzed by 5 alpha-reductase[1]. Alpha-Estradiol (17 Alpha-estradiol, 10 μM) attenuates LPS-induced inflammatory markers in both C57BL/6J male and female mouse embryonic fibroblast (MEF) cells, primary pre-adipocytes and differentiated 3T3-L1 adipocytes in an ERα-dependent manner, and such effects are through decreased NFκB-p65 and increased ERα protein expression[2].
In Vivo Alpha-Estradiol (17-alpha-estradiol, 0.01, 0.1, 1 μg) significantly reduces the percentage of central avascular/total retina area of the mouse pups. Alpha-Estradiol (1 μg) markedly decreasesmalondialdehyde (MDA) levels on postnatal days (PND) 9, 13, and 17 in retinas of hyperoxia-exposed pups. Alpha-Estradiol (1 μg) also decreases the number of NADPH-oxidase-positive cells, NADPH oxidase concentration and activity in retinas of the pups. In the 1.0-μg Alpha-Estradiol-treated pups, VEGF retinal concentrations are high on PND 9 but lower on PND 14 and 17. The best effect in retinas of 1.0-μg Alpha-Estradiol-treated pups is partly reversed by ICI182780 on PND 14 and 17[3].
Cell Assay Mouse embryonic fibroblast (MEF) cells are treated for the indicated time with Alpha-Estradiol (17 α-E2) or 17 β-E2 at 10 μM concentration. Inflammation is induced by LPS at a concentration of 10 ng/mL either alone or in combination with the respective estrogen[2].
Animal Admin Newborn mice are randomLy assigned to six groups according to the kind of treatment: room air with vehicle injection (control, group 1), hyperoxia with vehicle injection (control, group 2), hyperoxia with 0.01 μg Alpha-Estradiol injection (group 3), hyperoxia with 0.1 μg Alpha-Estradiol injection (group 4), hyperoxia with 1.0 μg Alpha-Estradiol injection (group 5), and hyperoxia with 1.0 μg Alpha-Estradiol and 10.0 μg ICI182780 injection (antagonist of estrogen receptor α and β) (group 6). The pups receive daily subcutaneous injections of either Alpha-Estradiol in vehicle [dissolved in ethanol and diluted in 0.05 mL/mouse of phosphate-buffered saline (PBS)] or vehicle alone from postnatal days (PND) 7-16. On PND 7, the pups in the hyperoxia and Alpha-Estradiol-treatment groups are exposed to hyperoxia (75 ± 2 % O2) for 5 days (PND 7-12) and then returned to normoxia (room air) for 5 days, along with the nursing mothers, whereas pups in the normoxia group are kept in normoxia from PND 7-17. The pups are humanely euthanized on PND 9, 13 (14), and 17[3].
References

[1]. Schriefers H, et al. Inhibition of testosterone metabolism by 17-alpha-estradiol in rat liver slices. Arzneimittelforschung. 1991 Nov;41(11):1186-9.

[2]. Santos RS, et al. The effects of 17 alpha-estradiol to inhibit inflammation in vitro. Biol Sex Differ. 2017 Sep 6;8:30.

[3]. Zhang HB, et al. 17-Alpha-estradiol ameliorating oxygen-induced retinopathy in a murine model. Jpn J Ophthalmol. 2012 Jul;56(4):407-15.
Density 1.2±0.1 g/cm3
Boiling Point 445.9±45.0 °C at 760 mmHg
Melting Point 176-180ºC(lit.)
Molecular Formula C18H24O2
Molecular Weight 272.382
Flash Point 209.6±23.3 °C
Exact Mass 272.177643
PSA 40.46000
LogP 4.13
Vapour Pressure 0.0±1.1 mmHg at 25°C
Index of Refraction 1.599
Storage condition 0-6°C
Water Solubility ethanol: 50 mg/mL, clear, colorless

CHEMICAL IDENTIFICATION

RTECS NUMBER :
KG3750000
CHEMICAL NAME :
17-alpha-Estradiol
CAS REGISTRY NUMBER :
57-91-0
BEILSTEIN REFERENCE NO. :
2698044
LAST UPDATED :
199803
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C18-H24-O2
MOLECULAR WEIGHT :
272.42
WISWESSER LINE NOTATION :
L E5 B666TTT&J E1 FQ OQ 17-ALPHA

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
3 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Reproductive - Tumorigenic effects - uterine tumors

MUTATION DATA

TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Human Cells - not otherwise specified
DOSE/DURATION :
100 mg/L
REFERENCE :
JTEHD6 Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- Volume(issue)/page/year: 10,143,1982
Symbol GHS08
GHS08
Signal Word Warning
Hazard Statements H351
Precautionary Statements P281
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xn: Harmful;
Risk Phrases R40;R48
Safety Phrases 53-45-24/25-22
RIDADR UN 2811
WGK Germany 3
RTECS KG3750000

Chemsrc provides CAS#:57-91-0 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 57-91-0 | Chemsrc address: https://m.chemsrc.com/en/baike/252359.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved